Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-14

NEW MOLECULAR APPROACHES FOR IMPROVED VACCINES TO POULTRY DISEASES

Objectif



The poultry industry is facing increasing problems due to the emergence of progressively more virulent forms of pathogenic viruses, which require increasingly effective vaccines to prevent disease. However, vaccine strains aggressive enough to protect against these new viruses can themselves cause pathogenic effects. The aim of this project is to overcome this problem by identifying the specific peptides within vaccines which cause the strongest vaccine response in animals of particular genotypes, so that combinations of vaccine and host genotype can be developed which maximise both the strength and consistency of protection.
There has been rapid progress in understanding the manner in which the immune system recognises and reacts to foreign molecules, and it is now clear that this process depends crucially on the ability of molecules of the Major Histocompatibility Complex (MHC) to present small peptide fragments of proteins to the immune system. Only a small proportion of the peptide fragments present in viral proteins are presented in this way, and animals with different MHC molecules present distinct, very specific, subsets of these peptides. It is already known that chickens of some MHC types respond well to certain vaccines. By systematically extending this information it will be possible to identify animals of similar genotypes in commercial flocks. More dramatically, it will be possible to characterise the particular viral peptides these MHC types present, making it possible to improve vaccines both by increasing the proportion of these peptides in the vaccines and by matching particular vaccines to birds of particular MHC types. By identifying and selecting the MHC types present in flocks it will then be possible to optimise vaccination. Most significantly, this will make it possible to create vaccines in which different components are optimised to stimulate the maximum protection of a number of different host MHC types, creating a epidemiological situation much less favourable to the development of forms of the virus able to overcome the vaccine.
In this project, work will concentrate on infectious bursal disease virus (IBDV) and Marek's disease virus (MDV), the viruses that cause two of the most serious diseases of European poultry. These diseases are ideal candidates for this approach since in both cases, current vaccines suffer from the problems outlined above and MHC-related differences in response to current vaccines have already been shown.
These viruses rovide tests of this a roach for a relatively small and simple virus (IBDV) and for a large and highly complex virus (MDV).
Although this work is targeted at IBDV and MDV the methodology developed should apply equally to other vaccines both in poultry and in other farm animals, and may ultimately be of relevance to man

Champ scientifique (EuroSciVoc)

CORDIS classe les projets avec EuroSciVoc, une taxonomie multilingue des domaines scientifiques, grâce à un processus semi-automatique basé sur des techniques TLN. Voir: Le vocabulaire scientifique européen.

Vous devez vous identifier ou vous inscrire pour utiliser cette fonction

Thème(s)

Les appels à propositions sont divisés en thèmes. Un thème définit un sujet ou un domaine spécifique dans le cadre duquel les candidats peuvent soumettre des propositions. La description d’un thème comprend sa portée spécifique et l’impact attendu du projet financé.

Appel à propositions

Procédure par laquelle les candidats sont invités à soumettre des propositions de projet en vue de bénéficier d’un financement de l’UE.

Données non disponibles

Régime de financement

Régime de financement (ou «type d’action») à l’intérieur d’un programme présentant des caractéristiques communes. Le régime de financement précise le champ d’application de ce qui est financé, le taux de remboursement, les critères d’évaluation spécifiques pour bénéficier du financement et les formes simplifiées de couverture des coûts, telles que les montants forfaitaires.

CSC - Cost-sharing contracts

Coordinateur

BBSRC Institute for Animal Health
Contribution de l’UE
Aucune donnée
Adresse
Compton Laboratory Compton
RG20 7NN Newbury
Royaume-Uni

Voir sur la carte

Coût total

Les coûts totaux encourus par l’organisation concernée pour participer au projet, y compris les coûts directs et indirects. Ce montant est un sous-ensemble du budget global du projet.

Aucune donnée

Participants (7)

Mon livret 0 0